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Background: Young adolescents’ and their parents’ experiences with Attention-Deficit/Hyperactivity Disorder
(ADHD) and its treatment were explored to investigate beliefs and attitudes regarding use of stimulant medication,
and their influence on treatment decisions.
Methods: Using in-depth qualitative interviews, 12 adolescents with ADHD aged 12 – 15 years, and their parents
described their experiences of ADHD and its treatment. Twenty four interviews, 12 with adolescents and 12 with
their parents elicited detailed descriptions of beliefs about ADHD, attitudes about stimulant use and the circumstances
surrounding treatment decisions. Verbatim transcripts were iteratively analyzed by a team of researchers following
an interpretive interactionist framework.
Results: Young people offered three themes describing ADHD: 1) personality trait, 2) physical condition or
disorder, and 3) minor issue or concern. Regarding medication use, youth described 1) benefits, 2) changes in
sense of self, 3) adverse effects, and 4) desire to discontinue use. Parents’ beliefs were more homogeneous than
youth beliefs, describing ADHD as a disorder requiring treatment. Most parents noted benefits from stimulant
use. Themes were 1) medication as a last resort, 2) allowing the child to reach his or her potential; and 3)
concerns about adverse and long-term effects. Families described how responsibility for treatment decisions is
transferred from parent to adolescent over time.
Conclusions: Young adolescents can have different beliefs about ADHD and attitudes about medication use
from their parents. These beliefs and attitudes influence treatment adherence. Incorporating input from young
adolescents when making clinical decisions could potentially improve continuity of treatment for youth with
ADHD.Background
Psychostimulant medications are highly effective for
controlling the developmentally excessive inattention,
overactivity, and impulsivity characteristic of Attention-
Deficit/Hyperactivity Disorder (ADHD), as well as many
of the associated disruptive behaviours, academic and
social impairments [1]. If taken regularly, psychostimu-
lants continue to be effective for two to five years, although
clear documentation of long-term benefit remains elusive
[2-4]. Despite use of stimulants, teenagers with ADHD re-
main at high risk for poor outcomes of academic and social* Correspondence: alice.charach@sickkids.ca
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reproduction in any medium, provided the orunderachievement, substance use, and frequent motor ve-
hicle accidents [5]. Since rates of stimulant use decline as
children become adolescents [6], poor medication adherence
may be an important factor mediating poor outcomes.
Parents are the primary decision makers for young
children, and as such, previous research has largely ex-
amined use of medication from their perspective. Par-
ents describe the decision to use medications to treat
their child’s ADHD behaviors as a difficult one, and they
are more likely to start medications if they understand
ADHD as a neurobiological condition, and that stimu-
lant medications are safe [7-10]. Not surprisingly, par-
ents who believe medication is unacceptable are unlikely
to accept recommendations for use [11,12].
According to college students and older adolescents,
the youth’s personal role in deciding about medication
becomes increasingly important during adolescence [13,14].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Description of adolescents: sample
characteristics
N %
Sex, male 6 50
Age at interview
12–13 yrs 7 58
14–15 yrs 5 42
Age at diagnosis
7–8 yrs 5 42
9–10 yrs 4 33
11–12 yrs 2 17








C: combined; GAD: generalized anxiety disorder; LD: learning disorder;
IA: inattentive.
N: number of participants; ODD: oppositional defiant disorder; yrs: years;
% percent.
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associated with the youth’s willingness to accept treatment
and lessened awareness or concern about the stigma sur-
rounding ADHD and medication treatment [15]. Interviews
with teens with ADHD who use stimulants have shown that
youth perceive benefits of treatment, although these are usu-
ally accompanied by negative side effects [14,16,17]. How-
ever, large gaps remain in what is known about young
people’s experiences and how these influence medication
use.
Many clinicians note that poor family functioning or par-
ent–child conflict appears to play a role in discontinuation
of medication. Qualitative studies where children and
youth are interviewed provide a range of descriptions of
how young people experience ADHD. Some studies report
that children describe primarily negative experiences from
having ADHD,[18-20] whereas elsewhere youth describe
positive attributes of having ADHD or describe themselves
as no different from their peers [13,16] . Children rate
themselves as having fewer symptoms than their parents
rate them [21] and may see themselves as functioning well
compared with how others see them [22]. Parent and teen
attitudes about treatment for ADHD can differ, [15] and
these differences likely contribute to youth refusing to take
medication as directed, [13] and ultimately discontinuation
of stimulant treatment. To date, socio-cognitive models of
behavior regarding use of medications to treat ADHD have
focused primarily on the role of parental choice [10,23].
Costello et al. [24] applied the network episode model to
decisions about child mental health care, with an emphasis
on community, school and extended family influences. Re-
cent conceptions of this model emphasize that the young
person and his/her experience should be at the center of
the model, [25] whereas in practice this rarely seems to be
the case. Moreover, there is little evidence to inform clini-
cians about how and when to solicit input from young
people instead of, or in addition to, parents in making
treatment recommendations.
The current research explores the treatment experi-
ences of young adolescents with ADHD and their par-
ents in order to examine their beliefs about ADHD,
attitudes regarding stimulant medication, and the par-
ent–child decision-making process regarding the young
person’s medication use during the developmental tran-
sition to early adolescence.
Methods
The study methods and results are described in accord-
ance with guidelines provided in the consolidated cri-
teria for reporting qualitative research [26].
Sample
Participants were twelve adolescents with a current or
past diagnosis of ADHD and their parents, for a total of24 interviews. The youth were chosen purposively to
provide a sample that was six females and six males, and
represented the age range from 12 to 15 years, with
seven youth aged 12–13 years and five youth aged 14–
15 years. In nine cases only the mother of the child par-
ticipated in the parent interview; in the remaining three
cases, both the mother and father of the adolescent par-
ticipated. The children were chosen to represent a range
of medication use histories. Seven youth were long-term
users of stimulant medication (four continuously, range
6 months to 6 years, and three intermittently, range 4 to
6 years), two youth had recently started medication for
the first time within the past 5 weeks, and three were
not using medication at the time of the interview, one of
these had had two brief trials and the other two had dis-
continued use one or more years previously. See Tables 1
and 2 for a description of the adolescents interviewed
and their medication status.
All youth had previously received a diagnostic assess-
ment at a specialty clinic for children with attention,
learning and behavior disorders. Inclusion criteria for the
adolescents were DSM IV diagnosis of ADHD, recom-
mendation of stimulant medication, age 12 to 15 years,
one or both parents willing to participate, and ability to
communicate in English. Youth who had other medical,
developmental or psychiatric conditions that required on-
going medical treatment were excluded.
Table 2 Description of adolescents: individual characteristics
ID Age (years) at Medication status Comorbid
Interview Diag On On & off D/C ADHD subtype LD GAD/dysth ODD
F6 12 8 5y C
M1 12 11 6mo IA x x
F5 12 12 < 1mo IA
M2 13 7 6y C x
M3 13 8 6y C x
M4 13 8 7y IA x x
F4 13 10 3y IA x
F1 14 8 Brief trials C x x
M5 14 9 On 6y, off 1y C x
M6 14 9 On 4y, off 3y C x
F3 14 14 < 1mo IA x x
F2 15 10 2y IA x
C: combined; Diag: diagnosis at specialty clinic (some children were diagnosed by community MDs prior); D/C: discontinued psychostimulants; dysth: dysthymia; F:
female; GAD: generalized anxiety disorder; LD: learning disorder; IA: inattentive; ID: case identification; M: male; mo: month; ODD: oppositional defiant disorder; >
1 yr: on psychostimulants more than 1 year; < 1 mo: on psychostimulants less than 1 month.
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cians as likely to be willing to talk about their treatment
experiences. Initially, one of the interviewers approached
parents first followed by the young person; three youth
preferred not to participate following their parent’s
agreement, while two others agreed to schedule inter-
views and participate in the study. We changed strat-
egies following these refusals and the interviewer
approached the youth first, followed by the parent.
None of the young people referred by their clinician
refused when approached before the parent. Only one
parent preferred not to participate. With this recruit-
ment strategy there were two families who did not
follow through with organizing an appointment fol-
lowing initial agreement to participate and a third
family who was not home when the interviewers ar-
rived, and could not easily reschedule with a follow
up phone contact. Young people who were actively in
treatment and using medication were more often re-
ferred by clinicians as willing to participate. As the
data collection and analysis progressed, we purposely
sought to speak with teens that had just started or
were no longer using medication to obtain a range of
subjective experiences. Clinicians were less able to
suggest youth to approach who met these adjusted
criteria. Both the adolescent and his/her parent or
parents were approached to discuss participation in the
study and interviews were scheduled at a subsequent time,
allowing potential participants to change their mind. For-
mal consent with the parent and assent with the child
were obtained immediately before the interviews accord-
ing to the protocol approved by the Hospital for Sick Chil-
dren Research Ethics Board, Toronto Ontario, Canada.Data collection
To ensure confidentiality, parents and youth were inter-
viewed separately by teams of two researchers (EY, TG
or AG) with experience in semi-structured interview
techniques. Sampling and data collection continued until
no new themes emerged regarding beliefs about ADHD
and attitudes about medication use, consistent with the
qualitative method underpinning this study.
The specific interview questions for the adolescents and
their parents covered similar content areas, although the
specific questions differed. The semi-structured interview
guide for youth was adapted from one that was used in a
focus group study examining subjective experiences of ad-
olescents’ formal and informal supports for their difficul-
ties with ADHD [23]. Questions and probes were selected
and adjusted to accommodate the research objectives of
the current study by the investigative team, which in-
cluded members with extensive experience interviewing
adolescents and their parents. For youth, we asked, “You
have been told you have ADHD…what does that mean to
you? In a typical day, how do you think having ADHD
makes things different for you?”; “Tell me about your ex-
periences with using medication for ADHD”, followed by
probes to elicit the child’s perspective regarding use of
medications in the contexts of school, home, with peers
and with family. In contrast, the parent interviews were
structured around questions related to the participant’s
past and present experiences seeking help for the child’s
ADHD, similar in design to previous research examining
parent experiences [7-9]. For example, the interviewer
asked parents, “Can you tell me something about your
child’s problems with learning, attention and behavior?
How did you decide that your child needed help?”; “Can
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your child with learning, attention, and behavior?”. The
aim of the interviews was to develop a “thick description”
of all participants’ personal experiences; that is, a descrip-
tion that describes the participant’s experience in detail,
including exploring the context surrounding each experi-
ence and the evolution of beliefs surrounding the experi-
ences [27]. The interviews lasted between 60 and
90 minutes. Eight pairs of interviews were completed in
the participants’ homes and four were conducted in the
clinic at the family’s preference.
Data analysis
Interviews and field notes were audio recorded and tran-
scribed verbatim. Analysis was conducted following the
interpretive interactionist framework set out by Denzin
[27]. Under this framework, key elements are identified
in individual interviews, compared across interviews to
construct a larger picture, and then re-contextualized
within the real world of the youth and parents.
In the initial phase of analysis, a team of four investiga-
tors representing several perspectives, including a pediatric
psychiatrist, a sociologist, an education researcher, and a
health researcher, independently read the transcripts and
identified specific codes. Team members compared notes
and developed a comprehensive code list through discus-
sion following the initial interviews. The team met regu-
larly and following each pair of interviews, the coding
manual was revised; codes were refined, collapsed, or elim-
inated as needed. The interview questions and prompts for
the semi-structured interview guides were also refined as
the data analysis progressed. Consistent with the epistem-
ology of qualitative research methods, the process of gener-
ating and refining codes continued until no new unique
codes were identified.
Using the coding manual developed, all transcripts
were compiled and organized using QSR International’s
NVivo 9 qualitative data analysis software [28]. One in-
vestigator coded each transcript, and half the transcripts
were recoded by a second investigator. Any discrepan-
cies between codes were discussed with the whole team
until 100% consensus was reached. The iterative process
of organizing codes into categories was reflexive, using
constant comparison between transcripts to identify
common and recurrent themes.
Trustworthiness of the findings was established through
accepted procedural strategies of credibility, dependability,
and confirmability as recommended by Linclon and
Guba [29]. Credibility was established through persistent
observation, prolonged engagement in the field, and over-
all development of the project; dependability was estab-
lished through an audit trail using fieldnotes, memo
writing, and reflexive notes; and confirmability through
multiple debriefings among the research team as theyreviewed the analysis, interpretation, and representation
of the data.Results
The interviews with the young adolescents and their par-
ents provided rich narratives of their experiences with
the diagnostic and the treatment process. In the first
section, youth beliefs about ADHD and attitudes about
medication treatment are summarized, with details pro-
vided in Tables 3 and 4. In the second section the parent
beliefs and attitudes are summarized, with details pro-
vided in Table 4. In the final section, comments from ad-
olescents and their parents describe the decision-making
process for medication use.Youth beliefs about ADHD
In the interviews, young people described how the diag-
nosis and symptoms of ADHD influenced their lives.
Three dominant themes emerged: 1) ADHD as a person-
ality trait, 2) ADHD as a physical condition or disorder,
and 3) ADHD as “being normal”, warranting minimal
concern. Several young people described characteristics
from more than one theme category. See Table 3.ADHD as a personality trait: If I didn’t have ADHD, I don’t
think I’d be me
For six youth, characteristics that might be attributed to
having ADHD played a significant role in their under-
standing of who they are. These youth experienced symp-
toms and behaviours associated with ADHD as unique
personality characteristics and a part of their self identity,
rather than as impairments.ADHD as a disorder: I can’t control the way my brain
works
In contrast to the view that ADHD is part of one’s per-
sonality, four youth understood it to be a disorder or ill-
ness that “happened” to them. These youth viewed
ADHD as a physical condition or disorder that should
be treated. Some youth who hold this ‘physical illness’
view of ADHD considered it to be less serious than
other chronic medical conditions.ADHD as being normal: I just lead a normal day, a normal
life
The third theme to emerge from participants’ narratives
characterized ADHD as “normal”. In these discussions
young people did not view their ADHD as impairing,
nor was their diagnosis something that they think about
frequently. Two youth had very little to say about how
having ADHD affects their lives.
Table 3 Adolescent beliefs about ADHD and attitudes about medication use
Beliefs about ADHD
Theme Quote Participant
1) Personality traits …if I didn’t have ADHD, I don’t think I’d be me. …’cause if I didn’t have ADHD I’d bet you I’d be
totally different.
M2
I mean, it doesn’t make it that different to have ADHD, …I don’t see myself any different than
anybody else.
F5
It’s just a part of me kind of, it’s who I am. M1
2) Physical condition “Yeah, I have ADHD, what can I do?” Like I can’t control the way I was born, I can’t control the
way my brain works.
F5
I would just say like it’s a disorder - that just…anyway it’s just screwing up my life. ‘Cause like I’m
treated kind of differently.
F6
I think I still have [ADHD] but there’s only certain times it will come up. Sort of like the flu. M5
Well there’s kids who have stuff worse than me like diabetes and cerebral palsy. F6
ADHD, I have nothing, like there’s kids in Sick Kids’ Hospital that have cancer…. F4
3) Being normal I don’t really care about most of this stuff. I just lead a normal day, a normal life. M3
Well for my mum it is [a problem] and for everyone else it is but with me, I don’t really care. M4
It’s not like something that’s like crossing my mind-ever. F2
Attitudes about medication use
Theme Quote Participant
1) Benefits Without uh the medication, I wouldn’t be, I don’t even think like I’d be in school. M2
I definitely get my work done. It [the medication] sort of makes me feel like more of a normal
student.
F2
It’s an obstacle when I’m not on the pill. M1
When I took them? …I’d have…my confidence would boost up quite a bit? F4
My parents, they’re a lot happier, and my brother’s coming to me and my grammas’s not yelling
at me anymore.
F5
2) Effects on sense of self I just like notice when I don’t take the medication I’m happier, I’m more perky, I can get along
with people.
F6
I’m more of the quiet person who just sits there. F4
I don’t really feel like myself when I take it. …. You can tell the difference like between weekend
me and school me.
F2
I felt weird; I didn’t feel normal. M6
I didn’t really like the idea ‘cause I thought it was going to alter my brain… M1
I just didn’t want it to like affect me that much …- I thought it would change me. F1
I think…in a way, [taking medication] makes me feel normal? But in a way it doesn’t make me
feel normal ‘cause it makes me feel a lot different from my friends.
F2
3) Adverse effects It gave me headaches ‘cause they were too strong. M5
Made me like depressed and really moody all after school. M4
I’m sent to the office because I feel sick and I have to throw up. …I just couldn’t stomach any,
eat anything.
F6
4) Desire to discontinue If I weren’t taking the meds, I’d go to school happy and I think I’d have a much better day. M4
I’m not crazy about the medication. I wish I could stop if I could. F6
I guess I can just stop whenever … I learn to sort of work without, like maybe after high school I
guess?
F2
But I don’t usually take it during weekends or during the summer …. F4
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For these young teens with ADHD, using stimulant
medication is a complex experience. Major themesdiscussed in the interviews were: 1) benefits of medica-
tion; 2) medication and sense of self; 3) adverse effects;
and 4) desire to discontinue medication. Most youth




Physical condition It’s really no different than somebody having something like cancer. They need to be treated. F1
… you have to wear glasses because you have poor eyesight, if you’re diabetic, you need insulin. F2
It’s almost as if there’s a cloud in the head, in his head that prevents his knowledge from coming out…. M1
Attitudes about medication use
Theme Quote Participant
mother of
Last resort I always said that it’s a last resort, OK? And I mean other things I’ve tried, nothing’s y’know, nothing has helped. F1
I’ve been very judgmental about the whole medication thing before whenever …someone had mentioned their
child had been on y’know Ritalin, I’d be like horrified.
F4
But yet we’re here trying it one more time, ‘cause he’s not doing well without it. M4
Learning aid I explained to him that he is very bright and…., for him to uh reach his potential. M1
I presented the medication to him as being a learning tool, …it might make things easier for him. M6
I guess when you see that your child has potential and they’re not fulfilling their potential …you sort of
realize [medication] is necessary.
F2
Adverse effects …Like you’re giving this child medication, you’re losing…your child–the personality, the qualities. …“Oh what
am I doing?”
F5
I guess part of me worries about any possible long-term damage that it can cause? M1
I don’t know how it’s [medication]going to affect him in the future? I don’t know how it will affect his kids. M2
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perience of using medication is multifaceted. While
some noticed benefits associated with stimulant treat-
ment, they still had concerns about adverse effects, as
well as the long-term implications of using medication.
Even among those who noted benefit, some described ef-
fects on their sense of self and discussed eventual dis-
continuation. See Table 3.The benefits of medication: It’s an obstacle when I’m not
on the pill
Youth noted positive experiences associated with taking
medication, most commonly in school or while complet-
ing homework. Others experienced “secondary” benefits
from medication, such as building their confidence in
the classroom as well as in social relationships.Medication and sense of self: The difference between
weekend me and school me
Approximately half the youth voiced concerns about the
medication changing who they are, either a concern held
when they had first started taking medication or as a
current undesirable effect. Those who commented that
psychostimulants changed their subjective experience of
themselves reported feeling less sociable or outgoing
when on the medication. Another experience described
was that taking medication made a young person feelmore like their peers, however, having to take medica-
tion also highlighted their apparent differences.
Adverse effects: I couldn’t stomach it
The experience of adverse effects by youth reflected
those known to be common with stimulant medication.
Participants reported a number of unwanted side effects
including difficulty sleeping, low appetite, mood swings,
and stomach aches. Other complaints included difficulty
swallowing the pills. The adverse effects experienced by
young people had a number of consequences, such as
trying different medications in search of one without
side effects, adjusting the dose, as well as deciding to
discontinue use.
Discontinuing medication: I wish I could stop
At the time of the interviews, three young people were
not currently using medication, while three others had
previously discontinued usage and had restarted a new
medication. Reasons given for stopping varied and in-
cluded adverse effects, insufficient benefit, and the feel-
ing that medication changed participants’ sense of self.
Although the majority of participants were using stimu-
lants at the time of the interview, a number of youth
spoke of resisting use through non-compliance, wishing
they could stop, or stopping at some unspecified time in
the future. In some cases, however, young people were ad-
herent and expressed satisfaction with their medication.
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was used, for example only when attending school.
Parent beliefs about ADHD
The interviews with parents revealed more homogeneity
in their ideas and thoughts about ADHD than was noted
among the adolescents. The majority of these parents
viewed ADHD as a chronic medical illness or physical
condition that required treatment or at the very least,
special accommodations. See Table 4.
Parent attitudes towards medication
Although the parents in our sample had children that
had used medication for varying lengths of time, from
just beginning to use medication to having used medica-
tion for several years, the transcripts revealed similar
themes across interviews. When seeking help for their
child, almost all parents: 1) viewed medication as a last
resort; 2) understood medication to be something that
helps their child reach his or her potential; 3) were con-
cerned about adverse and long-term effects. Many, but
not all, experienced benefits for their child, contributing
to their decision to use medication. This decision
process was complex and nuanced, and although all the
parents in our sample chose to use medication for their
child, several voiced uncertainty about that decision.
Medication as a last resort: I always said that it’s a last
resort
All parents commented that they were reluctant to begin
medication and many described it as a last resort. For
some parents, seeing the benefits after starting medica-
tion helped them understand that it was the “right”
treatment for their child.
Medication as aid to learning: They’re not fulfilling their
potential
Parents saw the main benefit of stimulant treatment to
be allowing their child to learn and function to the best
of their abilities. Parents commented that when they de-
cided to use medication, they hoped that it would allow
their child to reach their full potential.
Adverse and long-term effects: You really don’t know what
it’s going to do
While most parents of youth currently taking medica-
tion could see improvements and benefits, they were
also concerned about adverse effects and the potential
for long-term complications.
The decision-making process
Parents shared experiences about their choices to try
medication and the ongoing decision-making process of
continuing to use it or not. Over all parents describedthe initial decision, as largely parent driven, as the child
was often too young to participate.
…at that age, (grade 3) we told him this is what it was
gonna be. (Mother of M5)
Parents also described that as their child grew up, they
relinquished control over the decisions around medica-
tion use to varying degrees.
If he has work to do, he’ll usually choose to take the
four hour one? He sort of knows himself how much
time is required to do it. (Mother of M1)
According to one mother, the doctor broached the sub-
ject of going off meds and her son jumped at the chance.
I almost didn’t have a say any longer. (Mother of M5)
The transfer in responsibility described by parents was
reflected in youth narratives as well, with the young person
choosing whether to take medication some or all the time:
… mom gave me a choice. (F4)
…the decision is up to me. (M6)
I have told mom I will go back on [medication]. (F1)
Several themes accompanied the transfer of responsi-
bility to the young person, among them how the parent
perceived the young person’s maturity, “I think she real-
izes that she’s successful in school when she takes it”
(Mother of F2); a perceived need for the youth to be
more in charge of his /her life, “he’s going to be out in
the world soon, I can’t be mothering him.” (Mother of
M5); and, the youth’s increased ability to express him or
her self, “this year’s been different for a couple of reasons.
She’s older…started to voice her opinion.”(Mother of F6).
In some cases, the decision to discontinue medication
followed a series of different medication trials with less
than optimal results. For adolescents who had stopped
medication,
“it didn’t seem to be helping him sufficiently in school”
(Mother of M6).
Tension in the relationship between child and parent
regarding medication use was clearly present on more
than one occasion, a theme often expressed in the narra-
tives of both the young person and the parent.
Medication this, medication that…Well sometimes
medication doesn’t help! (F6)
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is gonna work… these are such crucial years. (Mother
of F6)
Participant M4 stated that it is annoying to take medi-
cation, because “my mom tries to force me to take it.” In
our interview with M4’s mother, she described a talk she
had with her son:
…we’ve promised your teachers, we’ve wasted (the
clinician's) time and y’know we need to try this…and
then I make him do it.
The young people currently in conflict with their par-
ents about using medication emphasized the lack of
benefit, the unpleasant adverse effects, and their happi-
ness when not taking it.
If I weren’t taking the meds, I’d go to school happy and
I think I’d have a much better day. (M4)
I just like notice when I don’t take the medication I’m
happier, I’m more perky. I can get along with people. (F6)
But I’m on this new stuff now? They’re putting me on
such a low dose that I don’t even think it’s going to
make a difference. (M4)
I think the medication…it’s kind of impairing my
learning because a lot of time I’m sent to the office
because I feel sick…. (F6)
Youth who had already discontinued using stimulants
echoed similar themes.
And I was kind of like, I would kind of like lose energy,
I was kind of tired. I felt kind of isolated. I felt kind of
overwhelmed. (M6)
In contrast, a number of young people recognized the
benefits, sometimes tolerating negative effects (i.e. being
quieter, less social), and chose to remain on medication
over time,
“makes me feel more like a normal student” (F2);
“there was a really big difference. (F4);
“like putting on a seat belt… like the one day I don’t
take it and I’m having a quiz …-I just don’t need that
day. (F2)
Not surprisingly, as the responsibility for decision-
making about medication use shifted from parent toadolescent, the youth’s subjective experience determined
whether or not they continued to take it on a regular
basis.
Discussion
Our interviews with young adolescents and their parents
revealed a more diverse range of beliefs and attitudes
about ADHD among young people than among their
parents. These differences underscore the importance of
the young person’s perspective in making decisions
about their treatment for ADHD. Several youth viewed
their ADHD as a chronic physical disorder, a belief
shared almost uniformly by the parents we interviewed.
While parents who held this belief generally expressed
support for medication use, this was not the case with
the young people. One youth who expressed this belief
(M5, see Tables 2 and 3) no longer took medication
while another described arguing with her mother about
continuing it (F5). Another belief expressed among ado-
lescents was that ADHD behaviors are part of who they
are, i.e., their self-identity, or are a minor inconvenience,
not affecting their day-to-day experience. The diversity
of comments elicited in the current study regarding the
personal meaning of ADHD mirrors the diversity noted
across and within qualitative studies of adolescents
[13,16,17,19,20]. Few of the young people interviewed in
this study emphasized negative meanings. The positive
comments heard here contrast with earlier reports that
children with ADHD frequently referred to themselves
as “bad” and may have difficulty describing positive attri-
butes of having ADHD [18,20]. On the other hand, these
positive beliefs about ADHD have also been noted else-
where [16] and echo the themes of positive group iden-
tity as discussed by Gajaria et al. [30] in their analysis of
public Facebook groups used by youth with ADHD. In
addition, these themes are reminiscent of the phenomenon
of positive illusory bias, where youth with ADHD do not
see themselves as functioning as poorly as others see them
[22]. Overall, however, such diversity of beliefs and attitudes
within and across samples of adolescents with ADHD is to
be expected, given the diversity of interview contexts and
investigator points of view, range of research questions,
non-standardized interview guides, methods of recruit-
ment, and generally small samples of volunteer participants
ranging in age from childhood to late adolescence.
The adolescents’ attitudes toward medication use
reflected their beliefs about ADHD. For example, wor-
ries expressed about having a changed personality with
medication maps onto the understanding of ADHD be-
haviors as a positive aspect of self. On the other hand,
descriptions of benefit with medication use may reflect
the theme of ADHD as a chronic disorder that requires
intervention. Young people who experienced benefit,
also described potentially unwanted effects, (F2, F4, see
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cations on school days, but not on weekends. Among
the children currently in conflict with parents over using
medication, the benefits of medication were not great
enough to outweigh the adverse effects (M4, F6 see
Table 3).
A unique aspect of our study was the concurrent
interviewing of young people and their parents, thereby
avoiding the potential for parents and children to dir-
ectly influence each other’s responses. Overall these par-
ents held a relatively homogenous conceptualization of
their children’s difficulties and the role of medication, in
contrast to the diverse views expressed by their children.
Consistent with previous studies of parental views, these
parents viewed ADHD as a long-term problem, with the
choice for medication treatment a “last resort”; and their
concerns centered on adverse and long-term physical ef-
fects [7-11]. As a group these parents anticipated that
medication use would help their children reach their full
potential, a theme more often voiced by parents who
choose medication than those who avoid it [10,11].
We heard from both parents and adolescents that as
the young persons grew older, they were given greater
responsibility by their parents and health care providers,
and their opinions increasingly dominated decisions
about medication use. Not surprisingly, the transfer of
decision-making from parent to youth occurred more
easily for those parent–child pairs where the adolescent
and the parent agreed about whether to use medication
or not. Our interviews captured two parent-youth pairs
who were in the midst of active conflict regarding use of
medication and for whom transfer of responsibility was
not an easy process. These examples provide a simultan-
eous parent–child lens on the increasing participation by
young teenagers in their treatment decisions about
ADHD.
The results of this study are exploratory and limitations
include the small sample recruited through a specialty
clinic where most families had a history of ongoing en-
gagement in treatment. While our sample may be small in
number, our goal is not to generalize results to large num-
bers of teens with ADHD but to investigate in-depth the
phenomenology of beliefs and attitudes about ADHD and
decisions about stimulant medication use, within the con-
textual frame of parent–child relationships and early ado-
lescence. The experiences of our sample reflect primarily
those of families engaged in ongoing treatment, and this
is an important group for whom understanding the
phenomenon of transferring medical decision-making
from parent to youth during early adolescence is highly
applicable. Indeed we purposefully sought out young
people who had recently started medication or who
were not taking medication at the time of the interview
in order to hear a variety of beliefs and attitudes andto capture descriptions of crucial moments in the par-
ent -child decision-making process. Parents in the
current study describe the process of transferring re-
sponsibility as they see their child becoming more cap-
able. In a study focused on medication treatment
decisions among ADHD youth, Brinkman et al. [13]
interviewed focus groups of adolescents, ages 13 to
18 years, recruited in primary care settings where the ma-
jority of stimulant medication is prescribed. They docu-
mented a range of participation in medication decisions
with some young people having full autonomy [13].
While there is some controversy in the field about
the concept of reaching saturation and when to stop
recruitment [31], we easily reached the point where
there were no new emerging themes on the primary
questions examining the beliefs and attitudes of young
people and those of their parents, as well as obtaining
subjective accounts of decision-making shifts from
parent to adolescent.
Overall, the study findings underline how the perspec-
tives of young people with ADHD may differ from their
parents in ways that have important implications for on-
going adherence to stimulant treatment. These prelimin-
ary results confirm that divergent opinions between a
youth and his or her parents can appear early in the teen
years. While clinicians who work with young people
know that adolescents should play an active role in their
own health care as they get older, the majority of pre-
scriptions for ADHD medications are written by primary
care practitioners [32], who are often busy and may or
may not have time to speak directly with the young per-
son themselves. Even for pediatric specialists, when and
how the transition from parent decision-making to joint
parent and teen decision-making should occur is not al-
ways clear. Many children remain quiet or passive dur-
ing treatment decision conversations and apparently
acquiesce to what the adults plan [13]. However, our re-
sults suggest that even when children accept the treat-
ment plan, their point of view may differ from that of
their parent. For some families, when young people do
not feel their opinions regarding treatment are heard, it
can become a source of parent–child conflict, or result
in poor treatment adherence. As clinicians who work
with adolescents know from experience, the best ap-
proach often includes a conversation with the young
person on his or her own, soliciting the young person’s
opinions and preferences, and offering opportunities to
ask questions. A subsequent joint conversation with
child and parent together is often required to complete
the planning process.
Conclusions
In summary, little evidence exists about the process of
health-care decision making for young adolescents and
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beliefs and attitudes about ADHD in children ages 12 to
15 sometimes differ from those of their parents. Not sur-
prisingly, the young person’s beliefs and attitudes have
increasing impact on medication use as decision-making
shifts from parent to youth. Clinicians can facilitate im-
proved medication adherence by working both with the
young adolescent as well as their parent when develop-
ing the treatment plan.
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